Ringpu Bio-Technology shareholders approve change in fund use

Tianjin Ringpu Bio-Technology Co., Ltd. held its fifth extraordinary general meeting of shareholders for 2025 on October 15, 2025, where shareholders approved a proposal to change the use of a portion of the company's raised funds. The resolution saw overwhelming support, with 194,220,731 votes in favor, representing 99.9271% of the valid votes cast. Opposition accounted for 123,400 votes (0.0635%), and 18,200 votes (0.0094%) were abstentions.

The meeting was conducted via a combination of on-site and online voting, with 159 shareholders attending and representing 194,362,331 shares, or 42.8047% of the company's total voting shares. The chairman was absent due to work commitments, and the meeting was presided over by general manager Xu Lei, as agreed by a majority of the board.

According to a legal opinion issued by Beijing Commerce & Finance Law Offices, the convocation, holding procedures, and voting results of the meeting fully complied with relevant laws and the company's articles of association, ensuring the legality and validity of the resolution.